These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

802 related articles for article (PubMed ID: 7905500)

  • 1. Effects of IL-12 on the response and susceptibility to experimental viral infections.
    Orange JS; Wolf SF; Biron CA
    J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
    Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
    J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection.
    Cousens LP; Orange JS; Biron CA
    J Immunol; 1995 Dec; 155(12):5690-9. PubMed ID: 7499855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-gamma production.
    Nguyen KB; Biron CA
    J Immunol; 1999 May; 162(9):5238-46. PubMed ID: 10227998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
    Kyburz D; Speiser DE; Aebischer T; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5051-8. PubMed ID: 7684417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection.
    McFarland HI; Nahill SR; Maciaszek JW; Welsh RM
    J Immunol; 1992 Aug; 149(4):1326-33. PubMed ID: 1500720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo state of antiviral CTL precursors. Characterization of a cycling cell population containing CTL precursors in immune mice.
    Razvi ES; Welsh RM; McFarland HI
    J Immunol; 1995 Jan; 154(2):620-32. PubMed ID: 7529281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections.
    Orange JS; Biron CA
    J Immunol; 1996 Feb; 156(3):1138-42. PubMed ID: 8557990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
    Yang HY; Dundon PL; Nahill SR; Welsh RM
    J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection.
    Von Herrath MG; Coon B; Oldstone MB
    Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins.
    Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection.
    Orange JS; Biron CA
    J Immunol; 1996 Jun; 156(12):4746-56. PubMed ID: 8648121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection.
    Salazar-Mather TP; Ishikawa R; Biron CA
    J Immunol; 1996 Oct; 157(7):3054-64. PubMed ID: 8816415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein.
    Zarozinski CC; Fynan EF; Selin LK; Robinson HL; Welsh RM
    J Immunol; 1995 Apr; 154(8):4010-7. PubMed ID: 7706740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA; Oldstone MB
    J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection.
    Moskophidis D; Assmann-Wischer U; Simon MM; Lehmann-Grube F
    Eur J Immunol; 1987 Jul; 17(7):937-42. PubMed ID: 2886344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the dynamics of LCMV infection in mice: conventional and exhaustive CTL responses.
    Bocharov GA
    J Theor Biol; 1998 Jun; 192(3):283-308. PubMed ID: 9650288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrogation of tolerance to a chronic viral infection.
    Jamieson BD; Somasundaram T; Ahmed R
    J Immunol; 1991 Nov; 147(10):3521-9. PubMed ID: 1940352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.